DOC vs VTR
Healthpeak Properties and Ventas, both Real Estate
Ventas is the larger company at $40B against $13B. On trailing earnings DOC is the cheaper of the two at a P/E of 67.4 against 176.4, a gap that is only a bargain if the two are growing at similar rates. Over the past year VTR returned +39% against +36% for DOC. Ryufin's sector-relative Smart Score puts VTR ahead, 7/10 against 6/10.
| Figure | DOC | VTR |
|---|---|---|
| Last close | $21.56 | $93.49 |
| Market cap | $13B | $40B |
| Trailing P/Elower is cheaper for the same earnings, not automatically better | 67.4 | 176.4 |
| Dividend yield | 5.7% | 2.1% |
| 1-year return | +36% | +39% |
| 5-year return | -23% | +84% |
| Ryufin Smart Scoresector-relative, 1–10 | 6/10 | 7/10 |
Figures from SEC filings and end-of-day closes. Highlighting marks the higher or lower number, which is not the same as the better investment, a low P/E can be a warning and a high one can be deserved.
Healthpeak Properties
Revenue of $753M in Q1 2026, net income $194M. Its largest reported line is Outpatient Medical Buildings, 47% of the disclosed total.
Ventas
Revenue of $1.7B in Q2 2026, net income $72M. Its largest reported line is Senior Housing Operating Portfolio SHOP, 50% of the disclosed total.
Open these two in the interactive comparison to add more names, change the period or read the correlation.